Dhanlaxmi Crop Science Ltd. (DHANLAXMI) AI Stock Analysis

Dhanlaxmi Crop Science Ltd.

(NSE:DHANLAXMI)

Select Model

Rating:41.9Neutral

Action:reiterated

Date:09/06/26

The overall score is driven primarily by weakening financial performance, with revenue decline, negative margins, and worsening cash flows posing significant risk, while a more conservative balance sheet offers some protection. A negative P/E ratio without supporting dividend data further pressures the rating, and the absence of usable technical, earnings-call, and corporate-event inputs means the assessment rests mainly on fundamentals and valuation.

Positive Factors

Improved leverageThe sharp reduction in debt-to-equity materially lowers balance-sheet risk compared with FY2022 and should provide more flexibility to manage operations or fund opportunities. Moderate leverage is a durable financial cushion, even though weaker profitability reduces the benefit of that cushion.

Negative Factors

FY2026 earnings reversalThe latest-year deterioration weakens confidence in near-term earnings durability: revenue contracted after two years of strong growth, operating profitability compressed sharply, and net income became negative. Sustained losses could limit reinvestment capacity and make recovery dependent on improved execution.

Dhanlaxmi Crop Science Ltd. Business Overview & Revenue Model

Company Description

Dhanlaxmi Crop Science Ltd. is an Indian enterprise specializing in the manufacture and processing of agricultural seeds. Established in 1994 and based in Himatnagar, India, the company boasts a comprehensive portfolio of crop and vegetable seeds. Th...

How the Company Makes Money

null

Dhanlaxmi Crop Science Ltd. Financial Statement Overview

Summary

The score reflects the transition from earlier strong growth and profitability to current revenue decline, margin compression, and sustained negative operating and free cash flows, partially offset by a strengthened, moderately leveraged balance sheet.

Income Statement

40Negative

Balance Sheet

62Positive

Cash Flow

28Negative

Financial statement breakdown
Breakdown	TTM	Mar 2025	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	381.43M	1.29B	381.29M	637.10M	466.11M	354.31M
Gross Profit	145.15M	208.60M	85.50M	121.98M	85.64M	55.26M
EBITDA	81.28M	126.13M	10.40M	68.78M	44.94M	15.32M
Net Income	50.96M	86.80M	-4.92M	46.78M	29.95M	5.83M
Balance Sheet
Total Assets	760.13M	829.16M	638.44M	349.62M	200.27M	208.63M
Cash, Cash Equivalents and Short-Term Investments	3.45M	138.89M	14.03M	10.99M	32.27M	14.38M
Total Debt	111.29M	71.72M	105.82M	10.42M	25.83M	91.32M
Total Liabilities	254.39M	369.78M	183.97M	188.41M	86.31M	146.91M
Stockholders Equity	505.74M	459.38M	454.46M	161.21M	113.96M	61.73M
Cash Flow
Free Cash Flow	-244.22M	-141.43M	-158.84M	-3.82M	62.80M	20.29M
Operating Cash Flow	-217.16M	-123.11M	-146.55M	827.00K	62.98M	20.29M
Investing Cash Flow	-24.19M	-15.38M	-12.42M	-4.63M	-9,000	2,000
Financing Cash Flow	242.50M	266.39M	34.10M	-17.48M	-45.08M	-12.02M

Dhanlaxmi Crop Science Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:DHANLAXMI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:GOKULAGRO	87Outperform	INR 63.44B	13.60	―	―	21.04%	59.07%
IN:GODREJAGRO	72Outperform	INR 106.57B	23.82	―	1.99%	8.58%	-1.86%
IN:INSECTICID	66Neutral	INR 15.10B	11.82	―	0.39%	1.26%	-16.43%
IN:KSCL	64Neutral	INR 34.15B	13.37	―	1.51%	-2.82%	-16.45%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:DHANLAXMI	42Neutral	―	-91.67	―	―	―	―

* General Sector Average

Performance Comparison

IN:DHANLAXMI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:CONTI	Continental Seeds & Chemicals Ltd.	9.85	-12.60	-56.12%
IN:GODREJAGRO	Godrej Agrovet Limited	553.85	-94.65	-14.59%
IN:GOKULAGRO	Gokul Agro Resources Ltd.	215.00	47.30	28.21%
IN:INSECTICID	Insecticides (India) Limited	519.10	-200.11	-27.82%
IN:KSCL	Kaveri Seed Co. Ltd.	663.80	-362.21	-35.30%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026

Dhanlaxmi Crop Science Ltd. AI Stock Analysis